JHL raises $45.6 million series C

JHL Biotech Inc. (Zhubei, Taiwan) raised $45.6 million in a series C round led by an undisclosed crossover investor. Existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management also participated.

The biosimilar developer and biologics manufacturer said it is preparing to list on Taiwan's Emerging Stock Board. ...